# Lura Health

> Lura Health is a Newark medical-device startup developing a miniature intraoral sensor that continuously samples saliva and sends readings to a phone for analysis and clinician review. Its first commercial focus is oral acidity and tooth-decay risk, with longer-term ambitions in glucose, electrolytes, metabolites and other biomarkers. The product remains in development and is not approved for sale in the United States.

- **Founded:** 2017
- **Headquarters:** Newark, United States
- **Founders:** Daniel Weinstein (Co-Founder and CEO), Saam Bozorg, DMD (Co-Founder and Chief Medical Officer), Noah Hill (Co-Founder and founding CTO)
- **Team size:** Approximately 14 employees, based on supplied company data; the public website names six current team members.
- **Products:** Continual Salivary Health Monitor, Oral Acid Monitor, M1000 oral pH sensor, Future biomarker modules
- **Notable:** Daniel Weinstein and Noah Hill were named to Forbes 30 Under 30 in Manufacturing & Industry for the 2021 class., Accepted into SOSV's HAX hardware accelerator in 2019., Awarded a $1 million NSF SBIR Phase II grant in 2022.

## Products & services

- **Continual Salivary Health Monitor** — A miniature intraoral sensor platform in development that records salivary analytes and sends data to a smartphone through Bluetooth Low Energy for cloud analysis and clinician review.
- **Oral Acid Monitor** — The first go-to-market application, designed to monitor saliva pH as an indicator associated with tooth decay and erosion risk.
- **M1000 oral pH sensor** — An earlier tooth-worn prototype combining pH and temperature sensing with Bluetooth connectivity.
- **Future biomarker modules** — Planned research applications include glucose, electrolytes, metabolites, therapeutic drugs and other salivary biomarkers; these are development ambitions, not marketed products.

## Achievements

- Daniel Weinstein and Noah Hill were named to Forbes 30 Under 30 in Manufacturing & Industry for the 2021 class.
- Accepted into SOSV's HAX hardware accelerator in 2019.
- Awarded a $1 million NSF SBIR Phase II grant in 2022.
- Granted U.S. Patent No. 11,638,535 for a long-term, continual, wireless intraoral monitor in 2023.
- Built an oral sensor module reported at less than 4 by 7 millimeters.
- Raised nearly $5 million from NSF, state grants and venture investors by 2024, according to MATTER.
- Selected for the inaugural AGA and MATTER GI care incubator in 2025.
- Secured strategic investment from SCO Group in 2025 and an additional investment in August 2026.

## Latest updates

- **2026-08** — SCO Group announced an additional investment to accelerate an oral-health platform combining intraoral sensing, AI, testing and data.
- **2026-05** — Lura completed the AGA and MATTER incubator cycle with a showcase at Digestive Disease Week 2026.
- **2025-11** — Lura joined 10 other startups in the inaugural AGA Incubator: Improving GI Care cohort.
- **2025-08** — Lura and SCO Group announced a strategic investment and business partnership for clinical pilots and eventual Asian expansion.
- **2024-11** — The company announced a $475,000 NSF SBIR Phase IIB award, bringing reported NSF support above $1.8 million.
- **2024-07** — Lura introduced a new brand identity and website centered on the category of continuous salivary monitoring.

## Links

- Website: https://lurahealth.com/
- LinkedIn: https://www.linkedin.com/company/lura-health/

---

Profile page: https://yespress.io/lura-health
Published by YesPress — https://yespress.io
Last updated: 2026-08-18